Verastem | VSTM - Interest Expense On Debt


Verastem reported $1.15M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Alaunos Therapeutics USD 1.07M 215K Jun/2023
AstraZeneca USD 484M 181M Dec/2025
Curis USD 178K 441K Dec/2023
Cytokinetics USD 30.33M 4.01M Dec/2025
Gilead Sciences USD 255M 1000K Dec/2025
Incyte USD 582K 10K Dec/2025
Laboratory Of America USD 55M 1000K Dec/2025
Novartis USD 304M 23M Dec/2025
Pfizer USD 711M 59M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
TG Therapeutics USD 6.53M 187K Dec/2025
Verastem USD 1.15M 10K Sep/2024